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OBJECTIVES: To first categorize a series of nephrectomies according to underlying pathology, as
practised in a major general hospital in the north of Jordan, and then compare the results with published
figures for Western countries. Also, to create standards for future evaluation of nephrectomies
performed by laparoscopy.
METHODS: The hospital and pathological records of 423 consecutive nephrectomies performed at
Princess Basma Teaching Hospital in the north of Jordan during the period of 1991–2000 were
reviewed.
RESULTS: Benign disease led to surgery in 298 cases, of which 161 were secondary to infection-
related conditions. Malignancy resulted in the removal of 125 kidneys. The rate of nephrectomy for
benign conditions has declined during the last few years in comparison with that for malignant
conditions. Patients operated on for benign diseases were younger (mean age, 38.4 years) than those
with malignant tumours (mean age, 46.7 years).
CONCLUSIONS: The mean age of patients undergoing surgery for benign and malignant disease was
lower than in publications from Western countries. The frequency of nephrectomy performed for
tuberculosis, hydatid disease, and xanthogranulomatous pyelonephritis is still higher than the rates
published in Western countries. There is a remarkably low frequency of upper urothelial carcinoma
compared with Western countries, probably due to environmental differences and genetic susceptibilities.
Malignant renal tumours tend to affect people at a remarkably young age in Jordan, which is thought
to be a reflection of the high proportion of young people. Nephrectomy for malignant disease had a
higher rate of complications (16.8%) than for benign conditions (9.4%; p < 0.0228). The re-operation
rate was 3.1% for all patients who underwent nephrectomy. The overall 30-day mortality rate was
0.9%. Both screening and education programmes are needed to decrease the rate of nephrectomy for
preventable conditions. (Asian J Surg 2002;25(2):163–9)
INTRODUCTION
Nephrectomy is a common procedure in surgical
practice. Simple nephrectomy is indicated in patients
with an irreversibly damaged kidney resulting from
symptomatic chronic infections, obstruction, calculus
disease or severe traumatic injury. It is, occasionally,
appropriate to remove a functioning kidney that is
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associated with one of these conditions when the patient’s
age or general condition is too poor to permit a
reconstructive operation, provided that the opposite kidney
is normal.
Nephrectomy may also be indicated to treat
renovascular hypertension from non-correctable renal
artery disease, or for severe unilateral parenchymal damage
resulting from nephrosclerosis, pyelonephritis, reflux
dysplasia, or congenital dysplasia. Although radical
nephrectomy is standard treatment for localized renal cell
carcinoma with a normal contralateral kidney, there is
growing interest in the use of nephron-sparing surgery for
select patients.
This review of 423 conventional nephrectomies carried
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model for Middle Eastern countries because the
demographic, racial, and economic features of these
populations are comparable. The purpose of the study
was to gain reliable information about indications,
morbidity, and mortality in order to set standards for
comparison with publications from Western countries.
Also, we aimed to create result-based intrahospital
standards for future evaluation of nephrectomies performed
using minimally invasive techniques. The long period
covered by this study enabled us to compare present and
past indications for nephrectomy in Jordan.
PATIENTS AND METHODS
A retrospective study was done on 431 consecutive
nephrectomies performed at Princess Basma Teaching
Hospital in Jordan during the period January 1991 to
December 2000. Eight nephrectomy patients were not
included in the study because their records were not
found in the archives, leaving 423 records available for
analysis. Data were collected from the hospital’s medical
records and the single pathology centre serving the area.
We obtained data regarding the following points: age at
presentation, gender, symptomatology, smoking habits,
laboratory investigations and imaging studies. These were
matched with the histopathology results.
The indications for nephrectomy were divided into
malignant and benign conditions. The first group was
subdivided into renal cell carcinomas (RCC), urothelial
carcinomas, nephroblastomas and other malignant
tumours. The benign group was subdivided into benign
tumours, infectious-related and non-infectious-related
conditions. Criteria for infection were defined as
preoperative pyuria, preoperative identification of infected
material, or histologically proven acute or chronic
infection. Another subgroup was classified as
miscellaneous, consisting of nephrectomies for anomalies,
trauma, or rejected kidney transplant.
The χ2 test was used for statistical analysis. A
p value of less than 0.05 was considered statistically
significant.
RESULTS
The number of nephrectomies studied was 423, of
which 238 were in males (56.3%) and 185 in females
(43.7%). The male-to-female ratio was 1.29:1. A malignant
tumour was the indication for nephrectomy in 125 cases
(29.6%), whereas 298 kidneys (70.4%) were removed
due to benign conditions (Table 1).
RCC was found in 91 kidneys (72.8%) with malignant
tumours; three of them were removed secondary to
recurrence from a contralateral primary kidney tumour.
Six (4.8%) of the malignant tumours were urothelial
carcinomas. Nephroblastoma was found in 21 children
(16.8%). The other seven malignant tumours consisted
of one case each of primary squamous cell carcinoma,
rhabdomyosarcoma, and renal invasion by a retro-
peritoneal sarcoma, two cases with invasion by an adrenal
carcinoma, and two cases of metastasis (breast and lung).
Of the benign kidneys, 161 (54%) were removed due
to infection-related conditions associated with end-stage
renal diseases: chronic pyelonephritis was detected in
117 cases, xanthogranulomatous pyelonephritis in 13
cases, pyonephrosis in 17 cases, tuberculosis in nine
cases, hydatid cysts in four cases, and one case with
emphysematous pyelonephritis. Renal stones were seen
in 44 cases with chronic pyelonephritis, 11 cases with
xanthogranulomatous pyelonephritis, four cases with
tuberculosis and in 14 cases with pyelonephrosis. The
reasons for nephrectomy in the non-infected group were
severely decreased kidney function in 29 patients and
renal hypertension in five patients. In our study, 73 cases
were classified as miscellaneous conditions consisting of
congenital anomalies, trauma, and rejected kidney
transplants in 44, 22, and seven patients, respectively.
Trauma led to 12 complete nephrectomies and 10 partial
nephrectomies. Additional trauma patients were not in-
cluded in the study because they underwent simple
kidney repair only.
During the last few years, nephrectomy for benign
conditions declined compared with malignant conditions.
In the first 5-year period of the last decade (1991–95),
158 operations were performed for benign con-
ditions compared with 140 in the last period (1996–2000)
 (p < 0.05) (Table 2).
Malignant tumours were significantly predominant in
males (p < 0.0001), while benign conditions were slightly
higher in females. Most of the malignant tumours occurred
on the left side. No side difference was found in the benign
groups. The mean age of patients with nephrectomy for
benign conditions was 38.4 years (range, 0.4–90 years),
while that for malignant diseases was 46.7 years (range,
0.25–80 years).
The majority of malignant renal tumours were
removed using a t ransabdominal  approach.
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Thoracoabdominal access was used in four cases of RCC.
Retroperitoneal access was mainly used for simple
nephrectomy in benign conditions, and for nephro-
ureterectomy in patients with urothelial carcinomas.
POSTOPERATIVE COMPLICATIONS, RE-OPERATIONS
AND MORTALITY
Postoperative complications occurred in 49 patients
(11.6%) (Table 3). Complications were significantly higher
in the malignant group (16.8%) than in the benign group
(9.4%; p < 0.0228). Pneumonia and haemorrhagic com-
plications were more frequent in the RCC group than the
other groups. Gastrointestinal (GI) complications were
particularly more frequent in the malignant group than the
other groups, with a highly statistically significant differ-
ence (p < 0.01). There was no statistically significant
difference in the rate of wound infection between the two
main groups (p < 0.10).
Thirteen patients (3.1%) were re-operated on for
complications: six patients (1.4%) for wound com-
plications, three (0.7%) for GI complications, three
(0.7%) for haemorrhagic complications, and one (0.2%)
for a missed swab. Re-operations for bleeding after
nephrectomy were done on one patient with left RCC and
one with right nephroblastoma; the bleeding occurred
from the suprarenal arteries in both. Bleeding from the
lumbar vessels after a nephrectomy for an infection-
related condition caused the third case. Ileus was the
reason for GI re-operation secondary to adhesions after
transabdominal operations in two patients with RCC and
for retroperitoneal sarcoma in the third. Six wound
infections had to be treated surgically; four of them
following surgery for infection-related conditions, one
after a post-traumatic partial nephrectomy, and the last
following RCC. Four patients had drainage for retroperi-
toneal abscesses, while two patients had debridement of
infected wounds.
Table 2. Change in the 5-year incidence of nephrectomy for malignant disease and benign conditions
Benign conditions Malignant conditions
1991–1995 158 53
1996–2000 140 72
Odds ratio = 1.5; p value using χ2 for 2 X 2 table < 0.05.
Table 1. Diagnosis and age distribution in 423 nephrectomies
Diagnosis Number of patients (%) Male: female ratio Mean age, years (range)
Malignant disease
Total 125 (29.6) 2.9:1 46.7 (0.25–80)
  Renal cell carcinoma 91 (21.5) 3.8:1 55.7 (7–80)
  Urothelial carcinoma 6 (1.4) 2:1 62.0 (45–75)
  Nephroblastoma  21 (5.0) 1.3:1 2.2 (0.25–5)
  Other malignancies  7 (1.7) 2.5:1 50.2 (39–62)
Benign disease
Total 298 (70.4) 1: 1.1 38.4 (0.4–90)
  Benign tumours 30 (7.1) 1: 1.7 42.4 (6–71)
  Infectious conditions 161 (38.1) 1: 1.4 42.8 (6–90)
  Noninfectious conditions 34 (8.0) 1.4: 1 41.3 (8–63)
  Miscellaneous 73 (17.2) 1.9: 1 25.8 (0.4–57)
Total 423 1.29: 1
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Table 3. Postoperative complications in 423 nephrectomies
Diagnosis/complication Haemorrhage Gastrointestinal Wound Pneumonia AMI Others Total
complications infection (%)
Malignant disease (n = 125)
  Renal cell carcinoma (n = 91) 2 4 2 3 1 2 14 (15.4%)
  Urothelial (n = 6) 0 1 0 0 0 0 1 (16.7%)
  Nephroblastomas (n = 21) 1 2 0 0 0 0 3 (14.3%)
  Other malignancies (n = 7) 0 1 1 0 0 1 3 (42.9%)
Benign disease (n = 298)
  Benign tumours (n = 30) 0 1 1 0 0 1 3 (10.0%)
  Infectious conditions (n = 161) 1 1 8 1 1 1 13 (8.1%)
  Noninfectious conditions (n = 34) 1 1 2 0 0 1 5 (14.7%)
  Miscellaneous (n = 73) 0 1 3 1 1 1 7 (9.6%)
Total 5 12 17 5 3 7 49 (11.6%)
The "Others" column includes deep vein thrombosis, pulmonary embolism and cerebrovascular incidents. AMI = acute
myocardial infarction.
Four patients (0.9%) died within the postoperative
period (< 30 days). Two died of advanced cancer, and two
of acute myocardial infarction (AMI) and pulmonary
infarction after surgery for benign conditions. There were
no statistically significant differences in mortality between
the benign and the malignant groups of patients.
DISCUSSION
The results of this study enable us to pathologically
classify the indications for nephrectomy in Jordan, and
perhaps other countries of similar socio-demographic
structures in the Middle East, for comparison with figures
in the West.
In 1966, Scott and Selzman described a rate of 29% for
neoplasia,1 while Schiff and Glazier presented a neopla-
sia rate of 38% a decade later.2 Beisland et al presented a
historical 20-year series of 646 consecutive nephrec-
tomies with a 61% neoplasia rate in Norway.3 In all of
these series, nephroureterectomies for urothelial
carcinomas were excluded. Excluding urothelial carci-
noma in the current study, we had a 28.5% neoplasia rate.
There was no significant increase in the incidence of
malignant tumours. The relative increase in the malignancy
rate, therefore, must be due to the considerable decrease
in nephrectomy for benign conditions, and the increase in
the number of people referred to our hospital. There are
likely to be several reasons for this: better management of
urinary tract infections, better control of hypertension,
and improvement in the management of renal stones
by minimal or non-invasive techniques (lithotripsy,
percutaneous nephrolithotomy). In addition, with better
understanding by physicians of the pathophysiology of
obstructive uropathy and the necessity for immediate
treatment and, thereby, the risk for serious functional
damage to the kidney, the frequency of nephrectomy has
been reduced.
Muscat et al found that the mean age for incidence of
RCC in men was 58.7 years, while it was 59.3 years in
women.4 Bretheau et al from France reported the mean
age for RCC as 62.1 years, with a male-to-female ratio of
2:1.5 In Norway, Beisland et al reported that the mean age
of the patients with RCC was 64.3 years (range, 15–90
years).3 In their series, patients operated on for benign
conditions were younger (mean age, 51.8 years) than
those with all types of malignant tumours of the kidney
(mean, 65.4 years).
In our study, patients operated on for benign conditions
were younger (mean age, 38.4 years) than those with
malignant tumours (mean, 46.7 years), the oldest being
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patients with urothelial carcinomas (mean, 62 years).
These figures are much lower than published ages in other
countries. This is largely because 50% of the Jordanian
people are below the age of 16 years (1996 census). The
youngest patient with renal adenocarcinoma was a
7-year-old child who was diagnosed after being
investigated for post-traumatic haematuria. RCC is an
uncommon tumour of childhood as it comprises only
2.3% to 6.6% of renal tumours in children,6–8 while
Wilm’s tumour constitutes 85% to 87%.9,10 The present
report shows that the mean age of patients with RCC is
55.7 years, which is still lower than those in the
aforementioned Western series. However, other cancers
such as breast cancer affect patients at a remarkably
young age in the Middle East.11
Nephron-sparing surgery appears to be a safe and
effective alternative to radical nephrectomy for localized
small renal tumours.12–14 Nine of our patients had this
type of surgery: three for small adenocarcinomas in
solitary kidneys, and six for small tumours of less than
5 cm; four of them proved to be adenocarcinoma and the
other two were oncocytoma.
There were 30 (7.1%) patients with benign tumours,
with a male-to-female ratio of 1: 1.7. In Norway, Beisland
et al reported 10 cases (1.6%) out of 646 nephrectomies
with a male-to-female ratio of 1:4.3 There are relatively
few updated reports in the literature on the epidemiology
of benign renal tumours.
In different studies, renal pelvis tumours accounted for
approximately 10% of all renal tumours and about 5% of
all urothelial tumours.15 Ureteral tumours are even more
uncommon, occurring with one-quarter the incidence of
renal pelvis tumours.16 Beisland et al reported 98 cases of
urothelial tumours, making up 15.2% of all the
nephrectomies presented and accounting for
approximately 22.4% of all renal tumours.3 We found
only six cases of upper urothelial tumours for which
nephroureterectomies were performed, accounting for
4.8% of all the renal tumours in our study. This remarkably
low frequency of upper urothelial carcinoma perhaps
reflects environmental differences from other areas and
possibly different genetic susceptibility. It is well known
that upper tract urothelial carcinoma has a higher incidence
in families afflicted with Balkan endemic nephropathy.17
This nephropathy may affect many people living in the
same house, but the pattern of its genetic transmission or
susceptibility, if one exists, is not clear.18 As a result,
family members who leave home at an early age may not
be affected, whereas those who join the family may
contract the illness.
In one report of 161 patients with end-stage renal
disease, 42 patients (26%) had “chronic pyelonephritis”
with bacteriuria in the past or at the time they were
studied.19 However, a complicating factor was involved
in all of the 42 patients with chronic pyelonephritis and
end-stage renal diseases: 66.7% had vesicoureteral reflux
(VUR); 14.3%, analgesic abuse; 11.9%, nephrolithiasis;
4.8%, pyelonephritis during pregnancy; and 2.4%,
hydronephrosis. In our study, several complicating fac-
tors were involved in most patients with nephrectomy due
to infection-related conditions (Table 4). Nephrolithiasis
was the commonest factor in our series, being confirmed
in 73 patients (45.3%). However, renal stones are very
common in this particular region of Mediterranean
countries.20,21 Other factors, like reflux nephropathy,
ureteropelvic junction obstruction, and pyelonephritis during
pregnancy were found in 43 (26.7%), 18 (11.2%), and 16
(9.9%) cases of infection-related nephrectomy, respectively.
We found 13 patients with xanthogranulomatous
pyelonephritis, accounting for 8.1% of all patients with
renal inflammation who were evaluated pathologically.
This figure is higher than those published in previous
reports (0.6%–1.4%).22,23 Eleven of these patients were
female, with a mean age of 50 years (range, 23–65 years),
Table 4. Complicating factors in patients undergoing nephrectomy for infection-related conditions (n = 161)
Complicating factor Number %
Nephrolithiasis 73 45.3
Reflux nephropathy 43 26.7
Ureteropelvic junction obstruction 18 11.2
Pyelonephritis during pregnancy 14 8.7
Unknown 13 8.1
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and three patients (23.1 %) were diabetic.
Beisland et al, found that five (0.8%) tuberculous
kidneys were removed out of 646 nephrectomies carried
out during 20 years at two Norwegian hospitals.3
We found nine (2.1%) tuberculous kidneys that were
severely diseased, and nephrectomy after efficient
chemotherapy was mandatory in each case. However,
Wong and Lau reported that 89.3% of all tuberculous
nonfunctioning kidneys had been destroyed and required
nephrectomy; in only three out of 28 cases was recon-
struction possible.24 Kerr and co-workers recommended
the removal of diseased organs.25
Isolated renal hydatid cyst is an uncommon
presentation of echinococcal disease, since renal
involvement occurs in only 2%–3% of cases.26,27 We
found five cases of renal hydatid disease; only the four
with nephrectomy were included in the study, with
cystectomy being performed for the last case.
The higher rate of nephrectomy for infected kidneys in
females is not surprising, as women are more prone to
urinary tract infections than men. Other benign conditions
have approximately equal distribution between males
and females. However, miscellaneous conditions are
approximately twice as common in males than females,
as trauma is more frequent in males. We found a
significantly higher rate of pneumonia in the malignant
group compared to nephrectomy for other conditions.
Out of the five patients who developed pneumomia
postoperatively, three had undergone transabdominal
surgery for RCC, and four of these patients were above the
age of 55 years. However, the choice of surgical approach
did not lead to significant differences in postoperative
complications, re-operations, or mortality (Table 5).
Thoracoabdominal access was ignored in the analysis
because of the small number of cases. The transabdomi-
nal approach may increase the risk for GI complications.
Schiff and Glazier reported a lower incidence of
complications when using an anterior retroperitoneal
approach,2 while Scott and Selzman found that
the transperitoneal approach gave a lower complication
rate.1 Swanson and Borges reported 19.1% postoperative
complications using midline incisions for renal
carcinomas.28 Beisland et al reported a 15.5% rate of
postoperative complications using different surgical
approaches.3 They also found a significantly higher rate of
postoperative complications for malignant disease
(17.6%) than for benign conditions (11.0%). Similarly, in
our study, nephrectomy for malignant disease had a
significantly higher rate of complications (16.8%) than
operations for benign conditions (9.4%; p < 0.0228). Our
figures may be considered satisfactory, which is probably
because the mean age of our patients is lower than those
in publications from other countries and, thus, more fit for
anaesthesia and surgery.
Beisland et al reported a re-operation rate after
nephrectomy of 3.0% for all the conditions, while it
was 1.5% for bleeding after radical nephrectomy for
localized RCC (pT1–pT2).3 The present study showed a
re-operation rate of 3.1% for all the patients who
underwent nephrectomy, while it was 1.1% for bleeding
after radical nephrectomy for localized RCC.
The overall 30-day mortality within the RCC group
was 2.0%. Beisland et al had an approximately 3.4%
mortality rate within this group.3 In the present series, the
mortality rate of 0.7% after nephrectomy for benign
disease was significantly lower than that in other reports.3
There was no influence of the surgical approach on
postoperative mortality. Although a complication with
need for re-operation was considered in some reports
to be a bad prognostic sign with regard to survival,3
this was not the case in the present study. Postoperative
development of AMI, however, proved to be a bad
prognostic sign because one out of three patients who
developed AMI died postoperatively.
Table 5. Complications according to operative approach in 423 nephrectomies
Retroperitoneal Transabdominal p value
(n = 303) (n = 116)
Postoperative complications (%) 10.6 12.1 NS
Re-operations (%) 3.0 3.4 NS
Postoperative mortality (%) 0.7 0.9 NS
NS = not significant.
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